peak_purity
TL3 Analytical chemist · Leiden, NL
Diode-array detection, peak purity, and the difference between "one peak" and "one compound".
Joined 30 July 2024 · last posted 9h · groups: analytical-chemists
137 posts, newest first. Showing up to 150.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #91 · Meta › Announcements · 28 Jul 2026 · 5 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #77 · Analytics › Home & field testing · 20 Jul 2026 · 0 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Follow-up: Reading an interaction checker output critically Replied, post #54 · Practice › Interactions · 19 Jul 2026 · 5 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #62 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 11 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #7 · Clinical › Bloodwork · 16 Jul 2026 · 26 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #89 · Analytics › Home & field testing · 15 Jul 2026 · 8 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #2 · Clinical › Prescriber conversations · 15 Jul 2026 · 0 likes Picking up the opening post: that is the part I would want checked first. Prescription logistics: confirm whether it will be filled locally, requires mail order, or…
-
Sulfonylureas: the interaction most worth taking seriously — what changed since Replied, post #6 · Practice › Interactions · 14 Jul 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #46 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Journal club: what we got wrong in an earlier session Replied, post #68 · Evidence › Journal club · 9 Jul 2026 · 3 likes I read post #66 twice before replying, because I had assumed the opposite. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #17 · Sourcing › Logistics · 8 Jul 2026 · 17 likes This follows post #14 rather than contradicting it. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #142 · Practice › Interactions · 8 Jul 2026 · 13 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #45 · Compounds › Retatrutide · 8 Jul 2026 · 7 likes This follows post #42 rather than contradicting it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose…
-
A promotion I argued against, and why I lost — a second dataset Replied, post #7 · Documentation › Doc review · 7 Jul 2026 · 3 likes I read post #5 twice before replying, because I had assumed the opposite. Evidence synthesis requests: if you think a page should summarise the state of evidence on a…
-
How to ask a question when you cannot say why you are asking it Replied, post #28 · Start Here › How to Ask · 2 Jul 2026 · 3 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #107 · Evidence › Journal club · 1 Jul 2026 · 10 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Submitting a sample: the process end to end Replied, post #48 · Sourcing › Independent verification · 30 Jun 2026 · 3 likes Worth separating two things that post #44 runs together. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #61 · Analytics › Impurities & related substances · 29 Jun 2026 · 31 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Revisiting: The best-written scientific paper you have read Replied, post #48 · Lounge › Off topic · 23 Jun 2026 · 16 likes I read post #46 twice before replying, because I had assumed the opposite. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of…
-
Asking a follow-up: new topic or new reply? Replied, post #13 · Start Here › How to Ask · 16 Jun 2026 · 0 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Prescription requirements and telehealth models — a second dataset Replied, post #66 · Sourcing › Regulatory · 15 Jun 2026 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #62 · Compounds › Semaglutide · 13 Jun 2026 · 23 likes Coming back to post #60, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #34 · Analytics › Home & field testing · 13 Jun 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #70 · Start Here › Welcome · 6 Jun 2026 · 0 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Tracking intake honestly when appetite is absent Replied, post #49 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 26 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Prescription requirements and telehealth models — a second dataset Replied, post #53 · Sourcing › Regulatory · 4 Jun 2026 · 19 likes I read post #51 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #52 · Practice › Storage & stability · 1 Jun 2026 · 21 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Shakes versus food: a pragmatic assessment Replied, post #13 · Nutrition & Training › Protein & intake · 30 May 2026 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #19 · Practice › Side effects · 30 May 2026 · 32 likes post #18 is right about the mechanism and I think understates the practical bit. Constipation: common, manageable, and frequently under-reported because it is not…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #47 · Clinical › Comorbidities · 20 May 2026 · 0 likes Coming back to post #45, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Recording a dissent on a document rather than suppressing it Replied, post #16 · Documentation › Doc review · 20 May 2026 · 7 likes On post #12 — agreed on the reasoning, with one qualification. New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #45 · Devices › Syringes & needles · 19 May 2026 · 9 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Coming back to: Time to steady state after a dose increase Replied, post #56 · Pharmacology › Pharmacokinetics · 18 May 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Sleep quality changes during weight loss Replied, post #20 · Wellbeing › Sleep · 11 May 2026 · 3 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Started this topic · Compounds › Secretagogues & GH axis · 30 Apr 2026 · 16 likes On the subject in the title: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Working notes rather than a conclusion. I have seen STEP…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #111 · Practice › Reconstitution · 25 Apr 2026 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #12 · Pharmacology › Receptor biology · 19 Apr 2026 · 0 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Official shortage notices and what they authorise Replied, post #2 · Access › Shortages · 9 Apr 2026 · 32 likes On the opening post — agreed on the reasoning, with one qualification. Communication from suppliers: a supplier having supply problems usually communicates them. If a…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #41 · Practice › Administration · 7 Apr 2026 · 8 likes Picking up post #38: that is the part I would want checked first. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether…
-
Spike-and-recover accuracy for a peptide assay Replied, post #7 · Analytics › Method validation · 6 Apr 2026 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #16 · Data & Tools › Calculators · 2 Apr 2026 · 0 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #67 · Practice › Interactions · 29 Mar 2026 · 30 likes post #66 answers the question as asked. The question underneath it is different. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Choosing which test to pay for, given a fixed budget Replied, post #32 · Sourcing › Independent verification · 20 Mar 2026 · 6 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #46 · Practice › Reconstitution · 18 Mar 2026 · 0 likes Picking up post #43: that is the part I would want checked first. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #3 · Start Here › Welcome · 9 Mar 2026 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. The compound and evidence pages are updated regularly and they are worth reading when…
-
The lowest dose that does anything: is that a real question? Started this topic · Practice › Dosing & titration · 28 Feb 2026 · 43 likes Asking directly, because I could not find a straight answer: The lowest dose that does anything: is that a real question? I have read the maintained page on this and I…
-
[2026 update] Journal club: PIONEER 6 as a safety trial Started this topic · Evidence › Journal club · 17 Feb 2026 · 6 likes Journal club: PIONEER 6 as a safety trial Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med ,…
-
Adsorption to container surfaces and to plastics Replied, post #13 · Pharmacology › Formulation chemistry · 31 Jan 2026 · 20 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
-
Preprint servers and what screening they do Replied, post #39 · Evidence › Preprints · 29 Jan 2026 · 17 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
The headache that turns out to be dehydration Replied, post #154 · Nutrition & Training › Hydration & electrolytes · 25 Jan 2026 · 2 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
What to include when your question involves a chromatogram Replied, post #31 · Start Here › How to Ask · 9 Jan 2026 · 0 likes This follows post #28 rather than contradicting it. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this…
-
The headache that turns out to be dehydration Replied, post #118 · Nutrition & Training › Hydration & electrolytes · 31 Dec 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Prescription requirements and telehealth models Replied, post #74 · Sourcing › Regulatory · 18 Dec 2025 · 30 likes Worth separating two things that post #70 runs together. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal…
-
DXA precision and the least significant change for lean mass Replied, post #67 · Outcomes › Body composition · 13 Dec 2025 · 1 like post #66 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Tracking a preprint to publication: a worked example Replied, post #107 · Evidence › Preprints · 11 Dec 2025 · 0 likes This follows post #104 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Reading SURMOUNT-1 without the press release Replied, post #92 · Compounds › Tirzepatide · 7 Dec 2025 · 7 likes Picking up post #89: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
Publishing an inconvenient result: a case study — the long version Replied, post #58 · Sourcing › Independent verification · 4 Dec 2025 · 2 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Started this topic · Evidence › Journal club · 2 Dec 2025 · 14 likes On the subject in the title: Revisiting: Journal club: SURMOUNT-1, read without the press release Working notes rather than a conclusion. Session topic: PIONEER 6 ( N…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #99 · Sourcing › Vendor reports · 27 Nov 2025 · 9 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Request: export my own posts — one year on Replied, post #16 · Meta › Feature requests · 27 Nov 2025 · 5 likes Coming back to post #14, because the follow-up matters more than the original answer. Deprecation requests: if you think a feature should be removed or changed, that is…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #12 · Compounds › Retatrutide · 26 Nov 2025 · 2 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Pen dose counters: what a click does and does not guarantee Replied, post #25 · Devices › Pens & autoinjectors · 14 Nov 2025 · 0 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
Availability by country, dated, with primary sources Replied, post #58 · Access › International · 13 Nov 2025 · 0 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #49 · Analytics › Home & field testing · 8 Nov 2025 · 21 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
When to stop reading forums, including this one Replied, post #43 · Wellbeing › Mental health · 31 Oct 2025 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What a purity-only report leaves out Replied, post #60 · Sourcing › Independent verification · 25 Oct 2025 · 24 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #15 · Compounds › Tirzepatide · 19 Oct 2025 · 5 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #10 · Compounds › Tirzepatide · 19 Oct 2025 · 19 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #53 · Analytics › COA interpretation · 16 Oct 2025 · 14 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #94 · Practice › Storage & stability · 13 Oct 2025 · 10 likes post #93 is right about the mechanism and I think understates the practical bit. Protecting from light: amber vials or opaque containers reduce light exposure. If you…
-
About the Feature requests category Replied, post #5 · Meta › Feature requests · 13 Oct 2025 · 3 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #68 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 26 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #65 · Practice › Storage & stability · 3 Oct 2025 · 0 likes On post #61 — agreed on the reasoning, with one qualification. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #58 · Practice › Storage & stability · 28 Sep 2025 · 25 likes I read post #56 twice before replying, because I had assumed the opposite. Published stability data applies specifically to the formulation studied, under the specific…
-
Hypertension improvement and when medication needs revisiting Replied, post #77 · Clinical › Comorbidities · 23 Sep 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #4 · Compounds › Retatrutide · 22 Sep 2025 · 1 like post #3 is right about the mechanism and I think understates the practical bit. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #110 · Access › Insurance & coverage · 7 Sep 2025 · 0 likes post #109 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Which panel is worth repeating and which is worth ignoring Replied, post #97 · Clinical › Bloodwork · 29 Aug 2025 · 0 likes post #96 answers the question as asked. The question underneath it is different. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #8 · Practice › Interactions · 26 Aug 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #31 · Pharmacology › Receptor biology · 25 Aug 2025 · 5 likes post #30 answers the question as asked. The question underneath it is different. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress…
-
What a documentation review can and cannot tell you Replied, post #84 · Sourcing › Independent verification · 22 Aug 2025 · 9 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #77 · Compounds › Secretagogues & GH axis · 19 Aug 2025 · 12 likes This follows post #74 rather than contradicting it. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might…
-
When a preprint is the best available evidence and we say so Replied, post #34 · Evidence › Preprints · 8 Aug 2025 · 0 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Titles that describe the question, not the situation Replied, post #64 · Start Here › How to Ask · 5 Aug 2025 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Are there stupid questions here? A staff answer, at length Replied, post #22 · Start Here › Welcome · 29 Jul 2025 · 10 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Reading a supplier's product description as a marketing document Replied, post #50 · Compounds › Other compounds · 28 Jul 2025 · 25 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Are there stupid questions here? A staff answer, at length Replied, post #13 · Start Here › Welcome · 25 Jul 2025 · 5 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #89 · Practice › Storage & stability · 17 Jul 2025 · 20 likes Worth separating two things that post #85 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Persistent vomiting and the threshold for seeking help Replied, post #5 · Safety › Adverse events · 12 Jul 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #18 · Compounds › Repair & healing peptides · 12 Jul 2025 · 15 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #64 · Compounds › Semaglutide · 11 Jul 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Coming back to: Official shortage notices and what they authorise Replied, post #53 · Access › Shortages · 10 Jul 2025 · 2 likes This follows post #50 rather than contradicting it. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and…
-
Triple agonism: additive, synergistic, or neither? Replied, post #64 · Compounds › Retatrutide · 5 Jul 2025 · 1 like post #63 answers the question as asked. The question underneath it is different. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
-
Repeatability versus intermediate precision Replied, post #111 · Analytics › Method validation · 1 Jul 2025 · 1 like Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #116 · Compounds › Tirzepatide · 21 Jun 2025 · 16 likes post #115 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #79 · Access › Insurance & coverage · 12 Jun 2025 · 1 like Worth separating two things that post #75 runs together. Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail…
-
Research-use-only labelling: what it means and what it does not Replied, post #2 · Sourcing › Regulatory · 7 Jun 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Official shortage notices and what they authorise Replied, post #17 · Access › Shortages · 30 May 2025 · 32 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #123 · Evidence › Journal club · 24 May 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #65 · Data & Tools › Calculators · 13 May 2025 · 0 likes Picking up post #62: that is the part I would want checked first. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #60 · Sourcing › Independent verification · 7 May 2025 · 0 likes On post #56 — agreed on the reasoning, with one qualification. How to submit a sample: contact the service directly. They will provide instructions on vial type,…
-
Follow-up: Documentation that appears only after payment Replied, post #29 · Sourcing › Red flags · 28 Apr 2025 · 26 likes This follows post #26 rather than contradicting it. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #15 · Devices › Syringes & needles · 26 Apr 2025 · 0 likes This follows post #12 rather than contradicting it. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant…
-
Follow-up: What other technical communities get right that we do not Replied, post #69 · Lounge › Off topic · 16 Apr 2025 · 17 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #13 · Clinical › Comorbidities · 5 Apr 2025 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
A page that has drifted out of date and needs a maintainer Replied, post #81 · Documentation › Wiki requests · 26 Mar 2025 · 8 likes This follows post #78 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Charge states for a 4 kDa peptide, worked through Replied, post #90 · Analytics › Mass spectrometry · 13 Mar 2025 · 5 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #44 · Analytics › COA interpretation · 3 Mar 2025 · 26 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Validating a method you did not develop — does this still hold? Replied, post #49 · Analytics › Method validation · 26 Feb 2025 · 19 likes Coming back to post #47, because the follow-up matters more than the original answer. Stability-indicating method: one that can separate a compound from its degradation…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #10 · Sourcing › Independent verification · 17 Feb 2025 · 1 like Picking up post #7: that is the part I would want checked first. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #2 · Analytics › COA interpretation · 14 Feb 2025 · 5 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Distinguishing a deletion sequence by mass alone Replied, post #82 · Analytics › Mass spectrometry · 13 Feb 2025 · 0 likes Picking up post #79: that is the part I would want checked first. Resolution: "high resolution" commonly means
-
Canadian access and provincial variation Replied, post #70 · Regional › North America · 8 Feb 2025 · 23 likes I read post #68 twice before replying, because I had assumed the opposite. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #12 · Documentation › Doc review · 5 Feb 2025 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #3 · Outcomes › Progress reports · 28 Jan 2025 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Protein density versus volume when you cannot eat much Replied, post #14 · Nutrition & Training › Protein & intake · 24 Jan 2025 · 3 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Gallbladder disease risk with rapid weight loss Replied, post #61 · Clinical › Comorbidities · 23 Jan 2025 · 3 likes This follows post #58 rather than contradicting it. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance.…
-
[2026 update] New subcategory: rationale and scope Replied, post #164 · Meta › Announcements · 19 Jan 2025 · 1 like Coming back to post #162, because the follow-up matters more than the original answer. Feedback to announcements: if you have feedback on an announced change (not a…
-
[2026 update] New subcategory: rationale and scope Replied, post #151 · Meta › Announcements · 15 Jan 2025 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Individual participant data versus aggregate data Replied, post #108 · Evidence › Meta-analyses · 12 Jan 2025 · 18 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #27 · Compounds › Oral incretins · 7 Jan 2025 · 18 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #96 · Compounds › Tirzepatide · 4 Jan 2025 · 23 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #4 · Practice › Dosing & titration · 19 Dec 2024 · 18 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Building a sensible monitoring schedule with your prescriber Replied, post #31 · Clinical › Bloodwork · 19 Dec 2024 · 7 likes post #30 answers the question as asked. The question underneath it is different. A single value outside interval: usually uninformative on a single draw. What makes a…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #2 · Meta › Wiki maintenance · 17 Dec 2024 · 30 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #28 · Evidence › Journal club · 15 Dec 2024 · 3 likes This follows post #25 rather than contradicting it. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people…
-
Body image changing more slowly than the body Replied, post #17 · Wellbeing › Mental health · 12 Dec 2024 · 6 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Two sessions a week versus four: what the evidence supports Replied, post #21 · Nutrition & Training › Resistance training · 2 Dec 2024 · 30 likes post #20 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #125 · Analytics › COA interpretation · 21 Nov 2024 · 0 likes Picking up post #122: that is the part I would want checked first. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old.…
-
[2026 update] New subcategory: rationale and scope Replied, post #14 · Meta › Announcements · 20 Nov 2024 · 21 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #3 · Evidence › Journal club · 14 Nov 2024 · 3 likes Worth separating two things that the opening post runs together. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #24 · Sourcing › Regulatory · 9 Nov 2024 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #37 · Clinical › Prescriber conversations · 6 Nov 2024 · 5 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
Requesting a page: what makes a good request — what changed since Replied, post #137 · Documentation › Wiki requests · 13 Oct 2024 · 21 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #3 · Compounds › Semaglutide · 10 Aug 2024 · 2 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Revisiting: A fridge failure and how I assessed the contents afterwards Replied, post #2 · Devices › Cold chain · 6 Aug 2024 · 0 likes Worth separating two things that the opening post runs together. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #4 · Practice › Dosing & titration · 22 May 2024 · 0 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…